世界の網膜色素変性症（網膜炎）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retinitis Pigmentosa (Retinitis) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4828
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、127ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、網膜色素変性症（網膜炎）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（一般治療、漢方、遺伝子治療、外科治療、その他）、用途別市場規模（病院、眼科クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・網膜色素変性症（網膜炎）の市場動向
・企業の競争状況、市場シェア
・網膜色素変性症（網膜炎）の種類別市場規模と予測2016-2027（一般治療、漢方、遺伝子治療、外科治療、その他）
・網膜色素変性症（網膜炎）の用途別市場規模と予測2016-2027（病院、眼科クリニック、その他）
・網膜色素変性症（網膜炎）の北米市場規模2016-2027（アメリカ、カナダ）
・網膜色素変性症（網膜炎）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・網膜色素変性症（網膜炎）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・網膜色素変性症（網膜炎）の中南米市場規模2016-2027（メキシコ、ブラジル）
・網膜色素変性症（網膜炎）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sanofi、Amgen、Amarantus Bioscience Holdings、Acucela、Applied Genetic Technologies Corp、Asklepios BioPharmaceutical、Astellas Pharma、Caladrius Biosciences、Dompe Farmaceutici SpA、Dormant Projects、GenSight Biologics SA、Grupo Ferrer Internacional SA、ID Pharma、InFlectis BioScience、Ionis Pharmaceuticals、Mimetogen Pharmaceuticals、M's Science Corp、Nanovector srl、Novartis AG、Novelion Therapeutics、ProQR Therapeutics、ReNeuron Group Plc、SanBio、Shire (Takeda Pharmaceutical)、Spark Therapeutics、Sun Pharma Advanced Research Company）
・結論

Retinitis pigmentosa is a kind of cortex on retinal pigment degeneration, chronic, progressive visual function, genetic, nutrition is not virtuous, retinal degenerative eye disease, the disease involving the eyes, men more than women, more incidence of 10 to 20 years old, a few people with the disease in the home, the faster progress in the earlier onset, curative effect is poorer, old age comes on slowly.

Market Analysis and Insights: Global Retinitis Pigmentosa (Retinitis) Market
The global Retinitis Pigmentosa (Retinitis) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinitis Pigmentosa (Retinitis) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinitis Pigmentosa (Retinitis) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinitis Pigmentosa (Retinitis) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinitis Pigmentosa (Retinitis) market.

Global Retinitis Pigmentosa (Retinitis) Scope and Market Size
Retinitis Pigmentosa (Retinitis) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinitis Pigmentosa (Retinitis) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
General Treatment
Traditional Chinese Medicine
Gene Therapy
The Surgical Treatment
Other

Segment by Application
Hospitals
Eye Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Amgen
Amarantus Bioscience Holdings
Acucela
Applied Genetic Technologies Corp
Asklepios BioPharmaceutical
Astellas Pharma
Caladrius Biosciences
Dompe Farmaceutici SpA
Dormant Projects
GenSight Biologics SA
Grupo Ferrer Internacional SA
ID Pharma
InFlectis BioScience
Ionis Pharmaceuticals
Mimetogen Pharmaceuticals
M’s Science Corp
Nanovector srl
Novartis AG
Novelion Therapeutics
ProQR Therapeutics
ReNeuron Group Plc
SanBio
Shire (Takeda Pharmaceutical)
Spark Therapeutics
Sun Pharma Advanced Research Company

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 General Treatment
1.2.3 Traditional Chinese Medicine
1.2.4 Gene Therapy
1.2.5 The Surgical Treatment
1.2.6 Other
1.3 Market by Application
1.3.1 Global Retinitis Pigmentosa (Retinitis) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retinitis Pigmentosa (Retinitis) Market Perspective (2016-2027)
2.2 Retinitis Pigmentosa (Retinitis) Growth Trends by Regions
2.2.1 Retinitis Pigmentosa (Retinitis) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinitis Pigmentosa (Retinitis) Historic Market Share by Regions (2016-2021)
2.2.3 Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Regions (2022-2027)
2.3 Retinitis Pigmentosa (Retinitis) Industry Dynamic
2.3.1 Retinitis Pigmentosa (Retinitis) Market Trends
2.3.2 Retinitis Pigmentosa (Retinitis) Market Drivers
2.3.3 Retinitis Pigmentosa (Retinitis) Market Challenges
2.3.4 Retinitis Pigmentosa (Retinitis) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retinitis Pigmentosa (Retinitis) Players by Revenue
3.1.1 Global Top Retinitis Pigmentosa (Retinitis) Players by Revenue (2016-2021)
3.1.2 Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Players (2016-2021)
3.2 Global Retinitis Pigmentosa (Retinitis) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinitis Pigmentosa (Retinitis) Revenue
3.4 Global Retinitis Pigmentosa (Retinitis) Market Concentration Ratio
3.4.1 Global Retinitis Pigmentosa (Retinitis) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinitis Pigmentosa (Retinitis) Revenue in 2020
3.5 Retinitis Pigmentosa (Retinitis) Key Players Head office and Area Served
3.6 Key Players Retinitis Pigmentosa (Retinitis) Product Solution and Service
3.7 Date of Enter into Retinitis Pigmentosa (Retinitis) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retinitis Pigmentosa (Retinitis) Breakdown Data by Type
4.1 Global Retinitis Pigmentosa (Retinitis) Historic Market Size by Type (2016-2021)
4.2 Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Type (2022-2027)

5 Retinitis Pigmentosa (Retinitis) Breakdown Data by Application
5.1 Global Retinitis Pigmentosa (Retinitis) Historic Market Size by Application (2016-2021)
5.2 Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retinitis Pigmentosa (Retinitis) Market Size (2016-2027)
6.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Type
6.2.1 North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021)
6.2.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027)
6.2.3 North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2027)
6.3 North America Retinitis Pigmentosa (Retinitis) Market Size by Application
6.3.1 North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021)
6.3.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027)
6.3.3 North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2027)
6.4 North America Retinitis Pigmentosa (Retinitis) Market Size by Country
6.4.1 North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2016-2021)
6.4.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retinitis Pigmentosa (Retinitis) Market Size (2016-2027)
7.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type
7.2.1 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021)
7.2.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027)
7.2.3 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2027)
7.3 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application
7.3.1 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021)
7.3.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027)
7.3.3 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2027)
7.4 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country
7.4.1 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2016-2021)
7.4.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size (2016-2027)
8.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type
8.2.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application
8.3.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region
8.4.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size (2016-2027)
9.2 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type
9.2.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021)
9.2.2 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027)
9.2.3 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2027)
9.3 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application
9.3.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021)
9.3.2 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027)
9.3.3 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2027)
9.4 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country
9.4.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2016-2021)
9.4.2 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size (2016-2027)
10.2 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Type
10.2.1 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Application
10.3.1 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country
10.4.1 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Retinitis Pigmentosa (Retinitis) Introduction
11.1.4 Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Retinitis Pigmentosa (Retinitis) Introduction
11.2.4 Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Amarantus Bioscience Holdings
11.3.1 Amarantus Bioscience Holdings Company Details
11.3.2 Amarantus Bioscience Holdings Business Overview
11.3.3 Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Introduction
11.3.4 Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.3.5 Amarantus Bioscience Holdings Recent Development
11.4 Acucela
11.4.1 Acucela Company Details
11.4.2 Acucela Business Overview
11.4.3 Acucela Retinitis Pigmentosa (Retinitis) Introduction
11.4.4 Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.4.5 Acucela Recent Development
11.5 Applied Genetic Technologies Corp
11.5.1 Applied Genetic Technologies Corp Company Details
11.5.2 Applied Genetic Technologies Corp Business Overview
11.5.3 Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Introduction
11.5.4 Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.5.5 Applied Genetic Technologies Corp Recent Development
11.6 Asklepios BioPharmaceutical
11.6.1 Asklepios BioPharmaceutical Company Details
11.6.2 Asklepios BioPharmaceutical Business Overview
11.6.3 Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Introduction
11.6.4 Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.6.5 Asklepios BioPharmaceutical Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Details
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Retinitis Pigmentosa (Retinitis) Introduction
11.7.4 Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.7.5 Astellas Pharma Recent Development
11.8 Caladrius Biosciences
11.8.1 Caladrius Biosciences Company Details
11.8.2 Caladrius Biosciences Business Overview
11.8.3 Caladrius Biosciences Retinitis Pigmentosa (Retinitis) Introduction
11.8.4 Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.8.5 Caladrius Biosciences Recent Development
11.9 Dompe Farmaceutici SpA
11.9.1 Dompe Farmaceutici SpA Company Details
11.9.2 Dompe Farmaceutici SpA Business Overview
11.9.3 Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Introduction
11.9.4 Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.9.5 Dompe Farmaceutici SpA Recent Development
11.10 Dormant Projects
11.10.1 Dormant Projects Company Details
11.10.2 Dormant Projects Business Overview
11.10.3 Dormant Projects Retinitis Pigmentosa (Retinitis) Introduction
11.10.4 Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.10.5 Dormant Projects Recent Development
11.11 GenSight Biologics SA
11.11.1 GenSight Biologics SA Company Details
11.11.2 GenSight Biologics SA Business Overview
11.11.3 GenSight Biologics SA Retinitis Pigmentosa (Retinitis) Introduction
11.11.4 GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.11.5 GenSight Biologics SA Recent Development
11.12 Grupo Ferrer Internacional SA
11.12.1 Grupo Ferrer Internacional SA Company Details
11.12.2 Grupo Ferrer Internacional SA Business Overview
11.12.3 Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis) Introduction
11.12.4 Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.12.5 Grupo Ferrer Internacional SA Recent Development
11.13 ID Pharma
11.13.1 ID Pharma Company Details
11.13.2 ID Pharma Business Overview
11.13.3 ID Pharma Retinitis Pigmentosa (Retinitis) Introduction
11.13.4 ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.13.5 ID Pharma Recent Development
11.14 InFlectis BioScience
11.14.1 InFlectis BioScience Company Details
11.14.2 InFlectis BioScience Business Overview
11.14.3 InFlectis BioScience Retinitis Pigmentosa (Retinitis) Introduction
11.14.4 InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.14.5 InFlectis BioScience Recent Development
11.15 Ionis Pharmaceuticals
11.15.1 Ionis Pharmaceuticals Company Details
11.15.2 Ionis Pharmaceuticals Business Overview
11.15.3 Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction
11.15.4 Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.15.5 Ionis Pharmaceuticals Recent Development
11.16 Mimetogen Pharmaceuticals
11.16.1 Mimetogen Pharmaceuticals Company Details
11.16.2 Mimetogen Pharmaceuticals Business Overview
11.16.3 Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction
11.16.4 Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.16.5 Mimetogen Pharmaceuticals Recent Development
11.17 M’s Science Corp
11.17.1 M’s Science Corp Company Details
11.17.2 M’s Science Corp Business Overview
11.17.3 M’s Science Corp Retinitis Pigmentosa (Retinitis) Introduction
11.17.4 M’s Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.17.5 M’s Science Corp Recent Development
11.18 Nanovector srl
11.18.1 Nanovector srl Company Details
11.18.2 Nanovector srl Business Overview
11.18.3 Nanovector srl Retinitis Pigmentosa (Retinitis) Introduction
11.18.4 Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.18.5 Nanovector srl Recent Development
11.18 Novartis AG
11.25.1 Novartis AG Company Details
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Retinitis Pigmentosa (Retinitis) Introduction
11.25.4 Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.25.5 Novartis AG Recent Development
11.20 Novelion Therapeutics
11.20.1 Novelion Therapeutics Company Details
11.20.2 Novelion Therapeutics Business Overview
11.20.3 Novelion Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
11.20.4 Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.20.5 Novelion Therapeutics Recent Development
11.21 ProQR Therapeutics
11.21.1 ProQR Therapeutics Company Details
11.21.2 ProQR Therapeutics Business Overview
11.21.3 ProQR Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
11.21.4 ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.21.5 ProQR Therapeutics Recent Development
11.22 ReNeuron Group Plc
11.22.1 ReNeuron Group Plc Company Details
11.22.2 ReNeuron Group Plc Business Overview
11.22.3 ReNeuron Group Plc Retinitis Pigmentosa (Retinitis) Introduction
11.22.4 ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.22.5 ReNeuron Group Plc Recent Development
11.23 SanBio
11.23.1 SanBio Company Details
11.23.2 SanBio Business Overview
11.23.3 SanBio Retinitis Pigmentosa (Retinitis) Introduction
11.23.4 SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.23.5 SanBio Recent Development
11.24 Shire (Takeda Pharmaceutical)
11.24.1 Shire (Takeda Pharmaceutical) Company Details
11.24.2 Shire (Takeda Pharmaceutical) Business Overview
11.24.3 Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis) Introduction
11.24.4 Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.24.5 Shire (Takeda Pharmaceutical) Recent Development
11.25 Spark Therapeutics
11.25.1 Spark Therapeutics Company Details
11.25.2 Spark Therapeutics Business Overview
11.25.3 Spark Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
11.25.4 Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.25.5 Spark Therapeutics Recent Development
11.26 Sun Pharma Advanced Research Company
11.26.1 Sun Pharma Advanced Research Company Company Details
11.26.2 Sun Pharma Advanced Research Company Business Overview
11.26.3 Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis) Introduction
11.26.4 Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
11.26.5 Sun Pharma Advanced Research Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of General Treatment
Table 3. Key Players of Traditional Chinese Medicine
Table 4. Key Players of Gene Therapy
Table 5. Key Players of The Surgical Treatment
Table 6. Key Players of Other
Table 7. Global Retinitis Pigmentosa (Retinitis) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retinitis Pigmentosa (Retinitis) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Retinitis Pigmentosa (Retinitis) Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Retinitis Pigmentosa (Retinitis) Market Share by Regions (2016-2021)
Table 11. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Retinitis Pigmentosa (Retinitis) Market Share by Regions (2022-2027)
Table 13. Retinitis Pigmentosa (Retinitis) Market Trends
Table 14. Retinitis Pigmentosa (Retinitis) Market Drivers
Table 15. Retinitis Pigmentosa (Retinitis) Market Challenges
Table 16. Retinitis Pigmentosa (Retinitis) Market Restraints
Table 17. Global Retinitis Pigmentosa (Retinitis) Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Retinitis Pigmentosa (Retinitis) Market Share by Players (2016-2021)
Table 19. Global Top Retinitis Pigmentosa (Retinitis) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinitis Pigmentosa (Retinitis) as of 2020)
Table 20. Ranking of Global Top Retinitis Pigmentosa (Retinitis) Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Retinitis Pigmentosa (Retinitis) Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinitis Pigmentosa (Retinitis) Product Solution and Service
Table 24. Date of Enter into Retinitis Pigmentosa (Retinitis) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2016-2021)
Table 28. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Retinitis Pigmentosa (Retinitis) Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Application (2016-2021)
Table 32. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2022-2027) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Retinitis Pigmentosa (Retinitis) Product
Table 67. Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Amgen Company Details
Table 70. Amgen Business Overview
Table 71. Amgen Retinitis Pigmentosa (Retinitis) Product
Table 72. Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. Amarantus Bioscience Holdings Company Details
Table 75. Amarantus Bioscience Holdings Business Overview
Table 76. Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Product
Table 77. Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 78. Amarantus Bioscience Holdings Recent Development
Table 79. Acucela Company Details
Table 80. Acucela Business Overview
Table 81. Acucela Retinitis Pigmentosa (Retinitis) Product
Table 82. Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 83. Acucela Recent Development
Table 84. Applied Genetic Technologies Corp Company Details
Table 85. Applied Genetic Technologies Corp Business Overview
Table 86. Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Product
Table 87. Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 88. Applied Genetic Technologies Corp Recent Development
Table 89. Asklepios BioPharmaceutical Company Details
Table 90. Asklepios BioPharmaceutical Business Overview
Table 91. Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Product
Table 92. Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 93. Asklepios BioPharmaceutical Recent Development
Table 94. Astellas Pharma Company Details
Table 95. Astellas Pharma Business Overview
Table 96. Astellas Pharma Retinitis Pigmentosa (Retinitis) Product
Table 97. Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 98. Astellas Pharma Recent Development
Table 99. Caladrius Biosciences Company Details
Table 100. Caladrius Biosciences Business Overview
Table 101. Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 102. Caladrius Biosciences Recent Development
Table 103. Dompe Farmaceutici SpA Company Details
Table 104. Dompe Farmaceutici SpA Business Overview
Table 105. Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Product
Table 106. Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 107. Dompe Farmaceutici SpA Recent Development
Table 108. Dormant Projects Company Details
Table 109. Dormant Projects Business Overview
Table 110. Dormant Projects Retinitis Pigmentosa (Retinitis) Product
Table 111. Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 112. Dormant Projects Recent Development
Table 113. GenSight Biologics SA Company Details
Table 114. GenSight Biologics SA Business Overview
Table 115. GenSight Biologics SA Retinitis Pigmentosa (Retinitis) Product
Table 116. GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 117. GenSight Biologics SA Recent Development
Table 118. Grupo Ferrer Internacional SA Company Details
Table 119. Grupo Ferrer Internacional SA Business Overview
Table 120. Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis) Product
Table 121. Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 122. Grupo Ferrer Internacional SA Recent Development
Table 123. ID Pharma Company Details
Table 124. ID Pharma Business Overview
Table 125. ID Pharma Retinitis Pigmentosa (Retinitis) Product
Table 126. ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 127. ID Pharma Recent Development
Table 128. InFlectis BioScience Company Details
Table 129. InFlectis BioScience Business Overview
Table 130. InFlectis BioScience Retinitis Pigmentosa (Retinitis) Product
Table 131. InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 132. InFlectis BioScience Recent Development
Table 133. Ionis Pharmaceuticals Company Details
Table 134. Ionis Pharmaceuticals Business Overview
Table 135. Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis) Product
Table 136. Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 137. Ionis Pharmaceuticals Recent Development
Table 138. Mimetogen Pharmaceuticals Company Details
Table 139. Mimetogen Pharmaceuticals Business Overview
Table 140. Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis) Product
Table 141. Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 142. Mimetogen Pharmaceuticals Recent Development
Table 143. M's Science Corp Company Details
Table 144. M's Science Corp Business Overview
Table 145. M's Science Corp Retinitis Pigmentosa (Retinitis) Product
Table 146. M's Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 147. M's Science Corp Recent Development
Table 148. Nanovector srl Company Details
Table 149. Nanovector srl Business Overview
Table 150. Nanovector srl Retinitis Pigmentosa (Retinitis) Product
Table 151. Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 152. Nanovector srl Recent Development
Table 153. Novartis AG Company Details
Table 154. Novartis AG Business Overview
Table 155. Novartis AG Retinitis Pigmentosa (Retinitis) Product
Table 156. Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 157. Novartis AG Recent Development
Table 158. Novelion Therapeutics Company Details
Table 159. Novelion Therapeutics Business Overview
Table 160. Novelion Therapeutics Retinitis Pigmentosa (Retinitis) Product
Table 161. Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 162. Novelion Therapeutics Recent Development
Table 163. ProQR Therapeutics Company Details
Table 164. ProQR Therapeutics Business Overview
Table 165. ProQR Therapeutics Retinitis Pigmentosa (Retinitis) Product
Table 166. ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 167. ProQR Therapeutics Recent Development
Table 168. ReNeuron Group Plc Company Details
Table 169. ReNeuron Group Plc Business Overview
Table 170. ReNeuron Group Plc Retinitis Pigmentosa (Retinitis) Product
Table 171. ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 172. ReNeuron Group Plc Recent Development
Table 173. SanBio Company Details
Table 174. SanBio Business Overview
Table 175. SanBio Retinitis Pigmentosa (Retinitis) Product
Table 176. SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 177. SanBio Recent Development
Table 178. Shire (Takeda Pharmaceutical) Company Details
Table 179. Shire (Takeda Pharmaceutical) Business Overview
Table 180. Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis)Product
Table 181. Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 182. Shire (Takeda Pharmaceutical) Recent Development
Table 183. Spark Therapeutics Company Details
Table 184. Spark Therapeutics Business Overview
Table 185. Spark Therapeutics Retinitis Pigmentosa (Retinitis) Product
Table 186. Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 187. Spark Therapeutics Recent Development
Table 188. Sun Pharma Advanced Research Company Company Details
Table 189. Sun Pharma Advanced Research Company Business Overview
Table 190. Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis) Product
Table 191. Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2016-2021) & (US$ Million)
Table 192. Sun Pharma Advanced Research Company Recent Development
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinitis Pigmentosa (Retinitis) Market Share by Type: 2020 VS 2027
Figure 2. General Treatment Features
Figure 3. Traditional Chinese Medicine Features
Figure 4. Gene Therapy Features
Figure 5. The Surgical Treatment Features
Figure 6. Other Features
Figure 7. Global Retinitis Pigmentosa (Retinitis) Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Eye Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Retinitis Pigmentosa (Retinitis) Report Years Considered
Figure 12. Global Retinitis Pigmentosa (Retinitis) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Retinitis Pigmentosa (Retinitis) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Retinitis Pigmentosa (Retinitis) Market Share by Regions: 2020 VS 2027
Figure 15. Global Retinitis Pigmentosa (Retinitis) Market Share by Regions (2022-2027)
Figure 16. Global Retinitis Pigmentosa (Retinitis) Market Share by Players in 2020
Figure 17. Global Top Retinitis Pigmentosa (Retinitis) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinitis Pigmentosa (Retinitis) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Retinitis Pigmentosa (Retinitis) Revenue in 2020
Figure 19. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2016-2021)
Figure 20. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2022-2027)
Figure 21. North America Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Retinitis Pigmentosa (Retinitis) Market Share by Type (2016-2027)
Figure 23. North America Retinitis Pigmentosa (Retinitis) Market Share by Application (2016-2027)
Figure 24. North America Retinitis Pigmentosa (Retinitis) Market Share by Country (2016-2027)
Figure 25. United States Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Retinitis Pigmentosa (Retinitis) Market Share by Type (2016-2027)
Figure 29. Europe Retinitis Pigmentosa (Retinitis) Market Share by Application (2016-2027)
Figure 30. Europe Retinitis Pigmentosa (Retinitis) Market Share by Country (2016-2027)
Figure 31. Germany Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Share by Region (2016-2027)
Figure 41. China Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Retinitis Pigmentosa (Retinitis) Market Share by Type (2016-2027)
Figure 49. Latin America Retinitis Pigmentosa (Retinitis) Market Share by Application (2016-2027)
Figure 50. Latin America Retinitis Pigmentosa (Retinitis) Market Share by Country (2016-2027)
Figure 51. Mexico Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Share by Country (2016-2027)
Figure 57. Turkey Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sanofi Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 62. Amarantus Bioscience Holdings Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 63. Acucela Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 64. Applied Genetic Technologies Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 65. Asklepios BioPharmaceutical Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 66. Astellas Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 67. Caladrius Biosciences Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 68. Dompe Farmaceutici SpA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 69. Dormant Projects Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 70. GenSight Biologics SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 71. Grupo Ferrer Internacional SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 72. ID Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 73. InFlectis BioScience Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 74. Ionis Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 75. Mimetogen Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 76. M's Science Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 77. Nanovector srl Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 78. Novartis AG Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 79. Novelion Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 80. ProQR Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 81. ReNeuron Group Plc Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 82. SanBio Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 83. Shire (Takeda Pharmaceutical) Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 84. Spark Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 85. Sun Pharma Advanced Research Company Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2016-2021)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

以下、関連資料のご紹介

網膜色素変性症治療のグローバル市場調査 2019年

Global Retinitis Pigmentosa Treatment Market Professional Survey Report 2019
QYR9NV11246 2019年11月14日 116Pages
※本調査レポートは、網膜色素変性症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、...

網膜色素変性症治療のグローバル市場調査 2019年

世界のエンテレグ（アルビモパン）市場規模・現状・予測（2021年-2027年）

Global Entereg (alvimopan) Market Size, Status and Forecast 2021-2027
QFJ1-5724 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、エンテレグ（アルビモパン）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12mgカプセル、タイプII）、用途別市場規模（腸部分切除、根治的膀胱切除術）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の消化器系用医薬品市場規模・現状・予測（2021年-2027年）

Global Digestive Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5705 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、消化器系用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア...

世界の3D動脈スピンラベル標識法(3D ASL)市場規模・現状・予測（2021年-2027年）

Global 3D Arterial Spin Labeling(3D ASL) Market Size, Status and Forecast 2021-2027
QFJ1-5054 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、3D動脈スピンラベル標識法(3D ASL)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CASL、PASL）、用途別市場規模（腫瘍、脳血管障害、神経変性疾患、パーキンソン病）、主要地域別市場規模（北...

世界のシムリン（プラムリンチド）市場規模・現状・予測（2021年-2027年）

Global Symlin (pramlintide) Market Size, Status and Forecast 2021-2027
QFJ1-6028 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、シムリン（プラムリンチド）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1.5mlペンインジェクター、2.7mlペンインジェクター）、用途別市場規模（I型糖尿病、II型糖尿病）、主要地域別市場規模（...

世界のアンチセンスオリゴヌクレオチド(ASO)市場規模・現状・予測（2021年-2027年）

Global Antisense Oligonucleotides Market Size, Status and Forecast 2021-2027
QFJ1-3837 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、アンチセンスオリゴヌクレオチド(ASO)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RNAアンチセンスオリゴヌクレオチド、DNAアンチセンスオリゴヌクレオチド）、用途別市場規模（病院、診療所、その...

世界の全血球計算（CBC）市場規模・現状・予測（2021年-2027年）

Global Complete Blood Count(CBC) Market Size, Status and Forecast 2021-2027
QFJ1-5129 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、全血球計算（CBC）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（WBC数、RBC数、血小板数）、用途別市場規模（病院、参照研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のレーバー先天性黒内障（LCA）市場規模・現状・予測（2021年-2027年）

Global Leber Congenital Amaurosis (LCA) Market Size, Status and Forecast 2021-2027
QFJ1-4418 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、レーバー先天性黒内障（LCA）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（乳幼児タイプ、小児タイプ）、用途別市場規模（病院、眼科クリニック、医療研究所、その他）、主要地域別市場規模（北米、アメリカ...

世界の全ゲノムシーケンシング（WGS）市場規模・現状・予測（2021年-2027年）

Global Whole Genome Sequencing (WGS) Market Size, Status and Forecast 2021-2027
QFJ1-5045 2021年6月 124Pages
QYResearch社発行の本調査レポートでは、全ゲノムシーケンシング（WGS）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（大規模全ゲノムシーケンス (> 5 Mb)、小規模全ゲノムシーケンス (≤ 5 Mb)）、用途別市場規模（人間、植物、動...

網膜色素変性症治療のグローバル市場調査 2019年 The global Retinitis Pigmentosa Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Retinitis Pigmentosa Treatment volume and value at global level, regional level and company level. From a gl…
網膜色素変性症治療のグローバル市場調査 2019年 The global Retinitis Pigmentosa Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Retinitis Pigmentosa Treatment volume and value at global level, regional level and company level. From a gl…
世界の新型コロナウイルス感染症用従来型漢方薬市場規模・現状・予測（2021年-2027年） At present, the global COVID-19 epidemic is progressing rapidly. Chinese medicine has a long history and plays an indispensable role in the prevention and treatment of various epidemics. During the treatment of COVID-19, the intervention of Chinese medicine has also achieved remarkable results. In 2…
世界の伝統型漢方薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Traditional Chinese Herbal Medicine Market The global Traditional Chinese Herbal Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
世界の遺伝子治療医学市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gene Therapy Medicine Market The global Gene Therapy Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…